SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-092335
Filing Date
2016-04-01
Accepted
2016-04-01 17:00:38
Documents
3
Period of Report
2016-04-01
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v435826_8k.htm 8-K 17354
2 EXHIBIT 3.1 v435826_ex3-1.htm EX-3.1 19278
3 EXHIBIT 3.2 v435826_ex3-2.htm EX-3.2 118336
  Complete submission text file 0001144204-16-092335.txt   156357
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 161547933
SIC: 2836 Biological Products, (No Diagnostic Substances)